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Four Decades of Structure Determination by
Mass Spectrometry: From Alkaloids to Heparin
Klaus Biemann
Department of Chemistry, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA
The early (1950’s and 1960’s) use of mass spectrometry in natural products chemistry and its
evolution to the present significance in biochemistry is recounted. This methodology allowed
the facile and speedy determination of the structure of a number of indole alkaloids, such as
sarpagine, quebrachamine, and two groups isolated from the roots of Aspidosperma quebracho
blanco. At the same time, the first strategy for the sequencing of small peptides by mass
spectrometry was demonstrated. It slowly advanced, over a period of two decades, to an
important alternative of the ubiquitous automated Edman degradation. Further advances in
methodology and instrumentation established mass spectrometry as today’s indispensable
tool for the characterization of proteins in biochemistry and biology. A new concept of the
ionization of highly acidic compounds as the protonated complexes with basic peptides, which
allows the accurate determination of the molecular weights of the former, a highly sensitive
method for the sequencing of heparin fragments and related sulfated glycosaminoglycans was
developed more recently. (J Am Soc Mass Spectrom 2002, 13, 1254-1272) © 2002 American
Society for Mass Spectrometry
In the 1950’s the most vigorously pursued researchefforts in organic chemistry concerned the study ofthe structure and chemistry of natural products and
the elucidation of the detailed mechanism of chemical
reactions. Both were fostered by developments before,
during, and after World War II. At that time rational
drug design was still a relatively unknown concept.
Instead, a search for pharmacologically and medically
useful plant products was on all over the world, espe-
cially in the tropics. Many of these were alkaloids,
because they could be most easily isolated by aqueous
acid from an otherwise complex plant extract.
An early success was an alkaloid isolated in 1932
from the root of Rauwolfia serpentina and named reser-
pine [1]. Its structure was not determined until 12 years
later [2]. Reserpine was one of the first antihypertensive
drugs and became a huge financial success for CIBA
(Basel, Switzerland) in the early 1950’s. Research labo-
ratories in the pharmaceutical industry and academia
raced to duplicate this achievement and shelves began
to fill with alkaloids, which had names and melting
points, but unfortunately, mostly lacked useful pharma-
cological activity.
The determination of the structure of these complex
molecules (aronatic-alicyclic, about 20 carbon atoms,
two nitrogens and a few oxygens) was tedious, time
and material-consuming. At that time (1950’s) it gener-
ally required degradation or conversion to known com-
pounds and establishing their identity using elemental
analysis (by combustion) and “mixed melting point”
[the melting point of a mixture of two identical com-
pounds is the same as that of each of the components,
while it is depressed if two different compounds of
same melting point are mixed], the gold standard of the
time. The understanding of reaction mechanisms in
vitro had led to the formulation of biosynthetic path-
ways in vivo, which aided in the postulation of struc-
tures that then could be proven by conventional means.
Ultraviolet spectra were used routinely for the detection
of chromophores, particularly aromatic substitution
patterns and infrared spectra came slowly into use.
Alkaloids
The circumstances that led me to choose mass spectro-
metry—a field at that time well established in physics,
the petroleum industry, and then analytical chemistry,
but virtually unknown among organic chemists—as my
area of research have been described earlier [3]. In 1957,
when I made the transition from a synthetic organic
chemist to instructor (in those days the bottom rung of
the tenure-track at MIT) in analytical chemistry, I had
been considering the determination of the structure of
sarpagine, an indole-alkaloid also isolated from R. ser-
pentina.
However, before I could design a proper strategy,
three research groups independently suggested [to limit
the number of references listed in this historical paper,
the interested reader is referred to further details
quoted in those cited here] structure 1. The aromatic
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Figure 1. Mass spectra of 3 from sarpagine, 2 from ajmaline, and of ibogaine (4) and ibogamine (5)
(reproduced from Reference [6], copyright 1960, with permission of Elsevier Science).
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portion was supported by UV-spectroscopy, but the
alicyclic system was chiefly based upon biogenetic
considerations. One of the papers [4] promised to
provide final proof of the structure by conversion of
sarpagine to 2, which can be made from another alka-
loid, ajmaline, of known structure [5]. No such report
appeared, probably because the conversion of 1 to 2
would be quite tedious, requiring the removal of an
aromatic and an aliphatic hydroxyl, introduction of a
methyl group at the indole-nitrogen, and reduction of a
double bond. The product would have to be purified to
constant melting point, followed by the proof of iden-
tity with 2 by mixed melting point.
It occurred to me that this correlation could be
accomplished much easier and requiring much less
material by comparison of the mass spectra of two
analogous, but not necessarily identical compounds.
Rather than removing the aromatic hydroxyl group,
which is very difficult, it was simply methylated; the
aliphatic hydroxyl group was removed by tosylation
and reduction, and the double bond was catalytically
hydrogenated to yield 3. Fortunately, the comparison
Compound 2 was easier to come by: It required only a
quick trip up the river to Professor Robert B. Wood-
ward’s laboratory at Harvard where it was sitting on
the shelf, left over from earlier work [5].
The mass spectra of 2 and 3 (Figure 1) exhibited a
remarkably similar pattern, shifted of course, in the m/z
values of the peaks due to the different substituents at
the aromatic system (methoxyl versus methyl  16).
Thus, what a sizeable Swiss research group could not
do in a couple of years, was accomplished [6] in a few
weeks by the use of mass spectrometry and a few
milligrams of sarpagine kindly provided by Dr. A.
Hofman.
It should be noted that these spectra were obtained
by electron ionization. In contrast to today’s widely
used “soft” ionization (CI, FAB, ESI, and MALDI) this
“hard” ionization generates molecular radical cations of
high excess energy which fragment extensively and
very reproducibly.
Because this proof of structure was novel and un-
precedented, it had to be shown that another isomer of
different carbon skeleton exhibits a different mass spec-
trum which is, however, specific for that type. Fortu-
nately, Dr. William I. Taylor (CIBA, Summit, NJ) had
such a pair at hand: Ibogaine (4) and ibogamine (5), the
structures of which he had determined shortly before
by conventional means [7]. The mass spectra of these
two alkaloids (Figure 1) indeed showed an identical
pattern (with a shift of 30 u, CH3O vesus H), which is,
however, very different from that exhibited by 2 and 3.
Having thus demonstrated the validity of the new
concept, which later became known as the “mass spec-
trometric shift technique”, it was enticing to look for
other examples, preferably indole alkaloids, for which
structures had been proposed but final proof was
difficult by conventional methods. One such case was
quebrachamine isolated long ago [8] from Aspidosperma
quebracho blanco. It was known to contain an indole-
system unsubstituted on its benzene ring and nitrogen,
and a tertiary amino group. However, there was no
functionality which could provide a site suitable for
selective degradation. The more drastic “zinc dust dis-
tillation”, another procedure in the tool chest of the
classical organic chemist, led to a complex mixture of
alkyl indoles and alkyl pyridines [9]. They were te-
diously purified by crystallization as picrates and iden-
tified by elemental analysis, melting points, and mixed
melting points when authentic samples were available.
As one of the earliest examples of a proton-NMR
spectrum used in this field, the presence of an unsub-
stituted indole was corroborated, but a previously sug-
gested N-methyl group could be ruled out [10]. The lack
of resolution and extensive chemical shift data at that
time did not allow the unraveling of the alicyclic
system. On the basis of all these rather meager data,
Witkop et al. suggested structures 6a or b for que-
brachamine [11]. A complete qualitative and quantita-
tive analysis of the pyridine mixture was required to
differentiate these two possibilities and would have
needed a much larger amount of the alkaloid than was
available.
Therefore, we repeated the Zn-dust distillation of
quebrachamine on a very small scale (13 mg). The mass
spectra of the pyridine fraction, after separation on a
packed GC column and collection of each peak, re-
vealed that the most abundant product by far was
3-ethylpyridine, while 3-methyl-5-ethylpyridine, which
had supported Structure 6b was a very minor component.
It could well have arisen by thermal rearrangement from
6a during the harsh conditions of the experiment. This
structure is closely related to aspidospermine, the major
alkaloid of Aspidosperma quebracho blanco. Its structure
(7a) had just been determined by x-ray crystallography
[12]. It was quite clear that cleavage of bond a in 7b
(desacetylaspidospermine) would generate 9, a me-
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thoxy analog of 6a enabling correlation of the two
structures by the mass spectrometric shift technique.
This conversion was easily accomplished by dehy-
dogenation of 6b to the indolenine 8 which could be
reduced with sodium borohydride to the ring-opened
form 9 [13]. The mass spectra (Figure 2) of que-
brachamine and 9 clearly exhibited the same pattern,
considering the identity of the fragments representing
the alicyclic system and the shift by 30 u for the
aromatic ones. The relative abundance of these frag-
ments would have been significantly altered for the less
highly branched isomer 6b.
The work described above produced not only ana-
logs varying in aromatic substituents (“substituent la-
beling”) but also isotope labeling by the use of catalytic
deuteration, LiAlD4 and NaBH4. Their mass spectra
made it possible to delineate the fragmentation path-
ways of these rather complex radical molecular ions
[13–15, 18].
When this work was presented at the IUPAC Con-
ference on Natural Products held in Melbourne, Aus-
tralia, in August 1960 it created much attention among
the leaders of this field and put mass spectrometry on
the map of organic chemistry. Indeed, right after the
lecture, Professor Carl Djerassi came up to invite me to
Stanford University to help with the installation of a
mass spectrometer in his laboratory and to train a
postdoc (who turned out to be Herbert Budzikiewicz) in
its operation and the interpretation of the spectra. He
recounted his impression 32 years later: “. . . It was the
elegant rationalization by Biemann et al. of the mass
spectral fragmentation behavior of alkaloids of the
aspidospermine class that stimulated a serious effort at
Stanford on organic chemical applications of mass spec-
trometry.” [16].
That elucidation of the fragmentation (Scheme 1) of
desacetylaspidospermine (7b), which leads to the mass
spectrum shown in Figure 3, prompted us to search for
other alkaloids produced by Aspidosperma quebracho
blanco. Upon injection of an extract of the bark of this
plant [because of the demand by pharmaceutical re-
search laboratories at that time, tropical plant materials
could be obtained commercially (in this case from S. P.
Penick and Co.)] into a packed GC column held at
265 °C, a chromatogram (Figure 4) was obtained, which
Figure 2. Mass spectra of (a) quebrachamine and (b) its methoxy analog derived from desacety-
laspidospermine (reproduced with permission from Reference [13], copyright 1962, American
Chemical Society).
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looks awful by today’s standards, but at that time it was
terrific. Fractions were collected individually by stick-
ing a melting point capillary over the exit of the column
and cooling it with a piece of dry ice. The capillary was
then placed into the heated inlet system of the CEC
21-103C mass spectrometer. The spectra revealed the
presence of at least 17 different alkaloids. Judging from
the easily discerened molecular weights, most of them
were new. It was clear from the spectra that there were
two types of carbon skeletons present. One (Group A),
recognized by the strong signal at m/z 124, corre-
sponded to the aspidospemine type (see Figure 3), but
the other one (group B), dominated by a peak at m/z 136
had to represent a different structural type.
When a larger portion of the extract was separated
on an alumina column using gravity chromatography,
sufficient pure material was obtained to record good,
individual mass spectra. Based on the mass and UV
spectra it was possible to assign structures to all the
components belonging to the aspidospermine class
(Group A, Figure 5). From what had been learned about
the spectra of several indole alkaloids and using the
mass shifts of the various components (Figure 6), it was
possible to assign Structure 10 to alkaloid 266B (Scheme
2) and its five congeners (Figure 7). The positions of
substituents on the benzene ring of the indole moiety
were again deduced from UV data. Quite a few of the
components were sufficiently abundant to crystallize so
that their melting points could also be determined. The
value for 338B (157–9 °C) compared well with 162 °C of
a substance isolated 80 years earlier [8] from the same
plant and named aspidospermatine. The identity of the
two compounds was further corroborated by elemental
analysis and optical rotation, the only other data re-
ported by Hesse who had assigned it a molecular
formula C22H28N2O2, i.e., a CH2 too much.
In the past it was common practice to report newly
discovered natural products after characterizing them
by their elemental composition (determined by com-
bustion) and melting point. A name was assigned,
generally based on a part of the botanical name of the
plant from which the product had been isolated. Since
we determined the structure of the new compounds
right after their isolation, we did not need to invent a
trivial name for each one of them but simply character-
ized them first by their molecular weight and structural
type. After the individual structures were determined,
we could derive a chemical terminology based on the
historical names aspidospermine and aspidospermatine
and using the common insert -idi- for the unsubstituted
analog.
When submitting the full paper for publication in
JACS, we ran into a problem with the Assistant Editor,
A. L. Autrey, who remarked in a letter dated October 9,
1962: “. . . More important is the need for pointing out
the restricted usefulness of the work in its present form
. . . the samples you have applied it [mass spectrometry]
to are open to question as to their homogeneity. You
have detected 20 compounds, but we question that you
Scheme 1
Figure 3. Mass spectrum of desacetylaspidospermine (7b). (Reproduced with permission from
Reference [18], copyright 1963, American Chemical Society.
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have “isolated” 16 of them. There is no demonstration,
other than by gas chromatography, of their purity.
None of the usual criteria of purity have been applied,
none have been characterized by classical means: No
melting points, no [combustion] analyses, few UV and
no IR spectra . . . . It is quite possible that in the future
natural product chemists will take the turn your work
has indicated, and that investigators will obtain mate-
rials, name them, and deduce their structures without
characterizing them in presently accepted ways. How-
ever, until this is more common, a clear indication of the
extent of your departure from past methods is neces-
sary.”
In his ardent defense of the status quo Dr. Autrey
had apparently also overlooked the fact that we had
determined the melting points of the more abundant
new compounds, which crystallized, and even burned a
few milligrams of 338B to compare the elemental anal-
ysis with Hesse’s data of 1882. It took a three-page
rebuttal and a copy of my book [17], which had just
appeared, to get the paper finally published [18]. For-
tunately, natural products chemists quickly accepted
and adopted our “departure from past methods”.
The need to establish elemental compositions by
combustion analysis, which required a few milligrams,
much more than needed for a mass spectrum and other
non-destructive spectral data (UV, IR, and later NMR)
was soon eliminated by the advent of high resolution
mass spectrometry. Inspired by J. Beynon’s use of the
“peak matching” method [19] for accurate mass mea-
surements with a Nier-Johnson double-focusing mass
spectrometer (MS-8, which became the commercial
MS-9 of AEI), we recorded complete high resolution
spectra on photographic plates exposed in a Mattauch-
Herzog instrument [17]. The ability to deduce the
elemental composition not only of the intact molecule,
but also of each one of the fragments in a single
experiment greatly facilitated the determination of
structures from that time on.
An example where high resolution data became
crucial was the determination of the structure of Vin-
blastine, a “dimeric” alkaloid of oncolytic activity. It
had been established previously that it consists of two
indole alkaloids, Velbanamine and Vindoline, but their
connectivity was unknown. Because of the size of this
molecule, elemental analyses were inconclusive, but the
exact mass of 810.4219 (a world record at the time)
established a composition of C46H58N4O9 [20]. The
composition of a number of key fragments allowed the
Figure 4. Gaschromatogram of the extract from the bark of Aspidosperma quebracho blanco. Slanted
lines bracket fraction collection. Code numbers indicate molecolar weight and patterntype (repro-
duced with permission from Reference [18], copyright 1963, American Chemical Society).
Figure 5. Structures of alkaloids belonging to group A (aspido-
spermine type).
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Figure 6. Mass spectra of alkaloid type B (reproduced with permission from Reference [18],
copyright 1963, American Chemical Society).
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determination of the complete structure of Vinblastine
(11) as well as that of the related Vincristine (12) [21].
This work continued until the end of the 1960’s when
we at MIT and Djerassi’s group at Stanford, as well as
others, had established the structures of close to hun-
dred alkaloids [22], in part or entirely by using mass
spectrometry in a way first demonstrated only a decade
earlier [6]. Now the shelves were bare and the quest for
new natural products of that category had subsided,
chiefly because none of them had become a block-buster
drug. A minor exception was vinblastine, for quite
some time the most useful medication for a relatively
rare type of leukemia, Hodgkin’s disease.
Early Instrumentation
In the light of today’s compact, microprocessor con-
trolled mass spectrometers incorporating sophisticated
data systems and sometimes even robotic sampling
devices, it may be educational, at least entertaining, to
look back almost half a century. Much of what is
described briefly in the following is outlined in detail in
Reference [17].
The Mass Spectrometer
At the time I planned to use mass spectrometry for the
determination of the structure of natural products, the
choice of commercially available instruments was prac-
tically limited to a single one: The Consolidated Elec-
trodynamics Corporation (CEC) model 21-103C (Figure
8). This was because of its dominance in the petroleum
industry and patent protection, which kept the fledg-
ling British AEI (Associated Electrical Industries, now
split into Kratos and Micromass, Manchester, UK) MS-2
and German ATLAS Werke (now Finnigan MAT, Bre-
men, Germany) CH-4 out of the United States. A further
selling point was the American Petroleum Institute’s
(API) collection of mass spectra, mainly of hydrocar-
bons and simple monofunctional organic compounds,
most of which had been recorded on instruments of the
21-103 series. The dominance of quantitative, analytical
applications of MS made this database very valuable
and provided good public relations for CEC.
Obtaining a mass spectrum was quite different from
the highly automated process of today. The sample had
to be vaporized into an all-glass inlet system held at up
to 200 °C. Enough sample (0.1–1 mg) was needed to
generate 102 mm Hg pressure in the reservoir from
which it leaked through a multi-hole molecular leak
(CEC’s dominating patent!) into the ion source. That
Scheme 2
Figure 7. Structures of alkaloids belonging to group B (aspido-
spermatine type).
Figure 8. The Consolidated Electrodynamics Corp. Model 21-
103C mass spectrometer. Left: Inlet system cabinet (in the author’s
laboratory, the top portion was enclosed and heatable to 250 °C);
center: 3-Coil electromagnet, the flight tube in the middle, main
pumping system housed below; right: Operator console (note the
round door in the upper left for retrieval of the photographic
recording paper).
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large amount was needed so that the pressure remained
relatively constant during the ca. 20 min. required to
record the spectrum. Scanning was by decreasing the
accelerating voltage from 3 kV to 300 V at constant
magnetic field, because that was easier and much more
reproducible than scanning the latter. The penalty was
a limited (1:10) mass range, and one thus had to record
a spectrum in two pieces (e.g., m/z 10–100 and say,
50–500) at two different magnetic field settings. Each
scan took about 5–10 min., limited by the recording
device, a 5-mirror galvanometer that deflected a light
beam onto a roll of photographic paper. At the end of
the scan, the paper had to be retrieved using a black silk
sleeve, taken to the darkroom, developed, fixed, and
dried. A quick inspection of the 1–2 m long record
showed whether the spectrum was any good and the
sample could be pumped out from the inlet system.
While the wet processing of the record was cumber-
some, it had the advantage of producing a permanent
record with a black-on-white trace. In that respect, the
self-developing UV-sensitive paper that came into use
somewhat later was a regression because the trace was
of low contrast and faded quickly in daylight. Attempts
to use a copy machine turned the record completely black.
While there was a “mass marker” (triggered by the
electric field), which put a dot on the bottom of the
record for every 10 mass units, it was not reliable
enough to establish the mass scale. Therefore, one had
to recognize the ever-present peaks at m/z 18, 28, 32, and
44, due to unavoidable air leaks, and then manually
count up from there. The high dynamic range of the
instrument made this quite easy, because the five gal-
vanometers had deflection ratios of 1:3:10:30:100, pro-
viding a range of better than 1:100,000 from full-scale on
the least sensitive trace. Once the mass scale was
established on the low mass scan, the bottom end of the
high-mass scan had to be matched and the counting
continued to the upper mass end (Figure 9). A good
checkpoint was always the characteristic pattern of the
mercury isotopes at m/z 196–204 (a free benefit pro-
vided by residual back-streaming from the Hg-diffu-
sion pumps used).
After establishing the m/z value of each peak, its
height had to be measured with a ruler and converted
to its absolute value by multiplication with the appro-
priate factor. Needless to say that it took quite some
time and effort until one could draw the type of
“bar-graph” nowadays instantly provided by the in-
strument’s data system. The tediousness of this process
had, however, two great advantages: First, it assured
that only very few but significant mass spectra were
recorded; and second, that the investigator had a lot of
time to think about each spectrum, and what it may
mean. I personally did almost all my thinking and
preliminary interpretations during these otherwise bor-
ing tasks.
The requirement to achieve a sample pressure of
about 102 mm Hg in a relative large sample reservoir
was dictated by the use of the mass spectrometer for the
quantitative analysis of hydrocarbon mixtures in the
petroleum industry. The procedure was, however,
wasteful as far as the required amount of sample was
concerned, and limited the methodology to compounds
that can be vaporized at 250 °C to achieve such a
pressure without decomposition. For our purposes the
precise reproducibility of relative intensities was not
important and we therefore tried to circumvent the
entire inlet system by vaporizing the sample directly
into the ion source, which required only a vapor pres-
sure of 106 mm Hg and to be maintained only in the
small volume of the ion source housing.
Preliminary experiments were carried out with a
Bendix time-of-flight (TOF) mass spectrometer. It was
equipped with a pyrolysis probe consisting of a resis-
tance-heated filament that could be placed below the
relatively open ion source through a vacuum lock. By
replacing that filament with a heating coil holding a
short piece of melting point capillary containing the
sample close to the ionizing electron beam, we were
able to obtain the mass spectra of intact, underivatized
nucleosides and amino acids [23]. Because of the infe-
rior resolution of the TOF spectrometer, we then con-
structed similar direct introduction probes for the CEC
21-103C and finally for the high-resolution mass spec-
trometer briefly outlined in the following.
As mentioned above in the section on dimeric indole
alkaloids, the determination of the elemental composi-
tion of the intact molecule and all the fragments thereof
via the measurement of exact mass became an impor-
tant tool in the beginning of the 1960’s. We chose the
CEC 21-110 model, because it was based on the Mat-
tauch-Herzog geometry, which allowed for the simul-
taneous focusing of the entire spectrum. By placing a
340  50 mm photographic plate into the focal plane,
one could record a complete high-resolution spectrum
during an exposure time of less than one minute. With
Figure 9. Part of the oscillograph record at high mass. Most
sensitive trace on top, least sensitive on bottom.
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a 1 mm high slot in a mask ahead of the focal plane, one
could accumulate up to 30 spectra onto one plate before
it had to be replaced through a vacuum lock (Figure 10).
Processing of the large amount of data represented
by each exposure required a number of steps: Measur-
ing the exact position of each of the often more than
hundred narrow lines along the plate by using a micro-
densitometer (also called “comparator”); conversion of
position to mass, based on the positions of lines from
perfluorokerosene always added as an internal mass
standard; and calculation of all possible elemental com-
positions that would fit within a specified limit (e.g.,
0.003 u). These principles were well known from
spark-source mass spectrometry, used for qualitative
and quantitative analysis of metals, alloys etc. In those
applications only a few lines were present and even
fewer needed to be measured, which could easily be
accomplished manually. In our case, hand measure-
ments and calculations sufficed to provide a feel for the
accuracy attainable, but not for general use.
Computers
Fortunately, MIT had begun to make its computer
center’s IBM 709 available to research in other depart-
ments, as long as one provided a FORTRAN program
for the task and the data to be processed, everything
punched into IBM cards. The results could be picked up
the next day, printed on reams of paper as well as
punched on cards for any further use. Punching the
measured distances onto the cards without mistakes
soon became too tedious and we began to automate the
entire process. A variable speed motor replaced the
hand-crank of the comparator, a numerical position
encoder mounted on its precision screw and another
one on the photomultiplier output. These two signals
were fed into a card punch operated in the continuous
mode. To avoid recording the useless data (95%) of
the baseline between the lines from one nominal mass
to the next, the operator slowed down the scanning
speed when a line (or multiplet of lines) approached
and pushed a button to activate the card punch. It was
part of the data processing algorithm to find the cen-
ter(s) of the line(s) from the profile recorded.
This system worked well for a while, but the number
of boxes of IBM cards that had to be moved back and
forth steadily increased and MIT’s computer center
started to charge ever higher user fees. When, in 1964,
NIH asked me (yes, at that time they sometimes asked)
to apply for one of the newly created National Research
Facility grants (now NCRR) to make high-resolution
mass spectrometry available to the biomedical commu-
nity, and also for a training grant in the same area, the
opportunity had come to set up my own computer
system. Again, the choice was very limited: The only
system then on the market and capable of recording
continuous data “on the fly” was the IBM 1800. Its
original purpose was to serve as a process monitor for
industrial plants. To put it into perspective with today’s
MS data processors, which in addition also control
much of the mass spectrometer’s operation and are
hidden within the instrument cabinet, the 1800 stood
about 6 feet high. The central processing unit (CPU)
operated with a core memory of 32,767 16-bit words,
from which data could be dumped on one of three
magnetic disks (12,000 words each) housed in a sepa-
rate cabinet (Figure 11). Thus, the total space to work
with was 135,534 bytes, less than one-tenth the capacity
of one of today’s 3 1/2 inch floppy disks! Final storage
was on digital tape. The entire system was first leased
for $50k annually, purchased for $250k two years later,
when its usefulness had been established.
Interfacing a new, specially designed comparator (D.
Mann, Burlington, MA) to the IBM 1800 system took
care of all the data generated by the high-resolution
mass spectrometers, of which we had two by 1965. It
also provided us with the opportunity to develop
methodologies to explore and utilize the vast amount of
information generated by continuously scanning low-
resolution mass spectrometers, especially when inter-
faced with a gas chromatograph (GCMS) (see next
section). We had already begun this work by recording
data on analog and digital tapes, but the installation of
the IBM 1800 made it possible to accomplish this for the
first time “on-line”. The process began with digitizing
the electron multiplier output of the computer-con-
trolled, continuously scanning (3 s/scan, m/z 40–600)
Hitachi RMU-6D mass spectrometer, defining all peak
centers, assigning its m/z value and storing all resulting
mass spectra on disk. For further processing other
concepts, most notably “mass chromatograms”, auto-
mated identification by “library searching”, etc. were
Figure 10. The author (standing left) discussing a photographic
plate with Walter McMurray and Peter Bommer (seated) in front
of the operator panel of the CEC 21-110 high-resolution mass
spectrometer (photo ca. 1982/1983).
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developed [24]. To facilitate inspection and interpreta-
tion of the entire data set “off-line” (“multi-tasking” of
the CPU was not possible at that time) each GCMS data
set (all spectra and all mass chromatograms) was auto-
matically put on a roll of microfilm by using a 16 mm
Bolex movie camera focused on a CRT screen, which
automatically displayed one spectrum and one mass
chromatogram after the other. The investigator then
could look at the data leisurely on any one of the film
readers we had around our laboratory.
While this system was never duplicated elsewhere,
instrument manufacturers began to incorporate the
concepts into their products as computer technology
rapidly advanced. Size and cost of processors decreased
while memory, speed and storage capacity increased
almost exponentially. In retrospect, NIH’s money hand-
somely paid its dividends for the benefit of the biomed-
ical (and chemical) community.
Gas Chromatography
In the mid 1950’s Professor E. R. H. Jones, University of
Manchester, UK, spent a summer at MIT and, almost
accidentally, told us about the usefulness of gas chro-
matography, which had just been invented by James
and Martin [25]. As an analytical method, it had not
immediately attracted the attention of organic chemists,
but Professor Jones’ examples of its use in the organic
synthesis laboratories of Imperial Chemical Industries
(ICI) in the UK made us aware of the unique signifi-
cance of this methodology. As a consequence, our
machine shop cranked out the necessary parts so that
each laboratory could put together its own “prepara-
tive” GC suited not only for the quantitative analysis of
reaction mixtures, but also for the isolation of their
components.
Compared to today’s gas chromatographs, the con-
traption was very simple, one may say primitive: It
employed a U-shaped glass tube packed with finely
ground firebrick (capillary columns were invented
much later) coated with Apiezon (a commonly available
purified stopcock grease). Helium (at about 30 mL/
min) passed first over a thermistor, then through the
column and again over another thermistor to exit. Both
were part of a Wheatstone bridge circuit and the
difference in current (representing differences in ther-
mal conductivity of the gas mixture) was displayed on
a strip-chart recorder, the only expensive part of the
contraption. The column was kept at constant temper-
ature (easy to implement, compared to the temperature
programming used much later).
Packed columns required, but also could accommo-
date, large (milligram) samples, an advantage for the
organic chemist. Constant temperature meant that vol-
atile components eluted fast at the beginning and less
volatile ones came off as broad peaks (see Figure 4). But,
if necessary, the mixture could be injected at two
different column temperatures to optimize resolution.
Most importantly, the detector was non-destructive, i.e.,
the effluent could be collected and used for further
experiments (record a mass spectrum or other data) or
re-injected for better resolution.
Collecting fractions was tedious and we, as well as
others, thought to overcome that step by interfacing the
exit port of the gas chromatograph directly to the ion
source of the mass spectrometer. This problem was
finally solved in a practical way simultaneously by
Ragnar Ryhage [26] and in our laboratory [27]. The
former used the diffusion principle, a jet orifice in front
of an aperture (modeled after processes previously used
for the separation of uranium isotopes as their hexafluo-
rides), while we used the faster effusion of small
molecules (helium) over large molecules through the
wall of a tube of fritted glass. Because the “Ryhage
separator” was patented, it could only be purchased
along with an entire LKB GCMS system, while the
“Watson-Biemann” separator (not patented) was freely
used by the other instrument manufacturers and with-
out royalties. These “carrier gas separators” were
needed because of the high flow rates required by
packed columns and the limited pumping capacity of
the mercury diffusion pumps of earlier mass spectrom-
eters. They became obsolete with the advent of capillary
columns, the commercial use of which was delayed in
the United States (compared to Europe) by a patent held
by the Perkin Elmer Corp. Efficient oil diffusion pumps
also could easily handle the lower gas flow rate of these
columns.
Peptides and Proteins
It took a little longer to convince the biochemists and
biologist of the usefulness of mass spectrometry al-
though my very first paper published in this field in
1959 outlined a strategy for the determination of the
amino acid sequence of small peptides [28]. Methodol-
ogies for peptide sequencing were still in their infan-
cies. Fred Sanger’s N-terminal labeling of di- and trip-
eptides with a dinitrophenyl group, followed by total
hydrolysis and identification of the labeled and unla-
belled amino acid(s) by paper chromatography, enabled
him to establish the first structure of a protein, insulin in
1953 [29]. At about the same time Pehr Edman began to
Figure 11. The IBM 1800 computer. Left: The CPU cabinet; the
banks of lights tell the operator (here Ed Ruiz) the status of
processing. Right: The cabinet holding three disks.
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develop the stepwise degradation of proteins from their
N-terminus [30].
I had planned to develop a chemical approach for the
labeling of the C-terminus of small peptides, to comple-
ment Sanger’s method, but as outlined earlier [3] aban-
doned that idea in favor of mass spectrometry. I real-
ized that peptides should be ideally suited for this
methodology because they represent linear molecules
of repeating backbone units substituted with a limited
set of side chains, all of which differ in mass with the
exception of the isomeric pair leucine and isoleucine,
and the isobaric glutamine and lysine. The main obsta-
cle was, of course, the utter involatility of these zwitte-
rionic molecules, which prevented their vaporization so
necessary for electron ionization. Here again, training in
organic chemistry came in handy, as I knew that this
could be overcome by acylation of the amino group(s)
and esterification of the carboxyl group(s). Further-
more, the polar amido groups could be converted to the
much less polar secondary amines (first step of Scheme
3). These reactions also caused the modified side chains
of glutamine and lysine to differ in mass. The use of
lithium aluminum deuteride instead of the hydride
avoided the side chain of aspartic acid to become
identical in mass to that of threonine. As I had predict-
ed—or at least hoped—the mass spectra of the prod-
ucts, ethyl-oligoethylenediamino alcohols were ex-
tremely simple due to their specific cleavage at the . . .
NH™CHR . . . bonds, resulting in sequence specific
fragments (Figure 12).
It was clear from the outset that any viable sequenc-
ing method had to be applicable to the complex peptide
mixtures resulting from the chemical or enzymatic
degradation of the protein of which the structure is to
be determined. Gas chromatography seemed to be the
method of choice. Compared to paper chromatography,
it had superior resolving power and loading capacity,
but made it even more important to use derivatives that
could be vaporized at atmospheric pressure, not just in
the vacuum of the mass spectrometer. The earliest
experiments already demonstrated [31] that the se-
quences of five peptides could be determined by mass
spectrometry after conversion of the mixture to amino-
alcohols, separation by GC, and collection of the com-
ponents as they eluted (similar to our alkaloid studies
described above) (Figure 13).
The development of mass spectrometric methods for
peptide and protein chemistry has been chronicled in
more detail elsewhere [32]. It took more than 15 years
from the original experiments until the first sequencing
of a small protein, subunit I (44 amino acids long) of
monellin, was accomplished by mass spectrometry [33].
For that work, the protein had to be subjected to partial
acid hydrolysis to generate the complex mixture of
many overlapping di- to hexapeptides. By that time we
had continuously improved the methodology through
the replacement of acetylation with trifluoroacetylation
Scheme 3
Figure 12. The mass spectrum of the reduction product of N-acetyl-isoleucyl-alanyl-proline methyl
ester (from Reference [31], copyright 1960, Elsevier Science [U.S.A.], reproduced with permission).
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[34] (second step of Scheme 3) and O-trimethylsilylation
[35] to increase volatility, which extended applicability
to these larger peptides. Direct coupling of the gas
chromatograph with the mass spectrometer [27] made it
possible to identify 61 peptides in the hydrolyzate of
monellin-I in a single experiment.
During the 1960’s the stepwise Edman degradation
had been essentially automated and had become the
mainstay of protein sequencing. Its major deficiency,
the inability to work on blocked N-terminal amino
acids, provided a niche for mass spectrometry which on
individual small peptides could not only deduce their
sequence but also identify the blocking group. Post-
translationally modified amino acids which were not
amenable to the Edman procedure, such as -carboxy-
glutamic acid, could be identified by mass spectro-
metry. Osteocalcin, a calcium-binding protein rich in
this component, could thus be successfully sequenced
by GCMS [36].
Furthermore, stretches of hydrophobic amino acids,
particularly toward the C-terminus, led to high losses of
material from the reaction vessel of the Edman appara-
tus because of “wash-out”. This had been one of the
difficulties in the Edman sequencing of monellin [37],
which has a very hydrophobic C-terminal sequence
-Gly-Pro-Val-Pro-Pro-Pro.
Extreme hydrophobicity is also a common character-
istic of trans-membrane proteins such as bacteriorho-
dopsin, the amino acid sequence of which could only be
determined correctly by a symbiosis of Edman degra-
dation and GCMS [38a, 38b]. This protein, which turned
out to be 248 amino acids long, was very resistant to
enzymatic cleavage because of its insolubility in water.
In aqueous suspension it was slowly attacked at a single
bond by chymotrypsin, producing two large peptides,
C-1 and C-2. These in turn could only be dissolved in
70% formic acid, the medium in which cyanogen bro-
mide (CNBr) cleaves at methionine, which is converted
to homoserine in the process. C-2, which contained five
methionines resulted in six peptides, CNBr-1 through
CNBr-5a and b. About two-thirds of the sequences of
CNBr-1 to CNBr-4 could be determined by the auto-
mated Edman degradation, but excessive washout pre-
cluded reaching the C-termini. CNBr-5a and b were too
short for this method.
The GCMS experiments carried out in parallel not
only confirmed the Edman data (Figure 14), but also
provided the information necessary to assemble the
complete sequence of C-2: (1) Establish the missing
C-terminal sequences; (2) sequence the short peptides
CNBr-5a and b; (3) identify the blocked N-terminus of
CNBr-2; and (4), most importantly, permit the proper
alignment of the six peptides to a single sequence. For
this, the amino acids adjacent to each of the five
methionines of C-2 had to be determined. This was
accomplished by partial acid hydrolysis of C-2, convert-
ing the complex mixture of peptides to the O-TMS
polyamino alcohol derivatives and injecting it into the
GCMS. The entire set of 250 scans was then searched for
ions specific for a sequence A-Met . . . (where A is any
amino acid), the minimum sequence for a peptide
defining an overlap. Using the principle of coinciding
mass chromatograms [24], the mass spectra of all me-
thionine-containing derivatives could be extracted from
the mass of data and their sequence determined [38a].
The same strategy was then successfully applied to the
larger C-1, thus completing the structure of bacteriorho-
dopsin [38b].
By 1980 it had become possible to sequence the gene
coding for a protein. However, the “reading” of the gels
was still beset with errors. Combination with an entirely
different approach employed simultaneously seemed to
be the most efficient strategy. Because of its high
sensitivity, our GCMS methodology for peptide se-
quencing was used to aid in the determination of the
amino acid sequence of very large proteins (some close
to 1000 amino acids long), such as aminoacyl-tRNA
synthetases [39]. By matching random, short amino acid
sequences obtained by GCMS continuously to the DNA
data as they were acquired, it was instantly possible to
see whether the latter were correct. A missing or
erroneously inserted nucleotide causes a “frame shift”,
which then translates into a fictitious amino acid se-
quence that would not appear in any of the GCMS data
produced from the real gene product, the protein. That
Figure 13. Gas chromatogram of the reduction product of a
mixture of five peptides (from Reference [31], copyright 1960,
Elsevier Science [U.S.A.], reproduced with permission).
Figure 14. The amino acid sequence of cyanogen bromide pep-
tides of C-2 of bacteriorhodopsin (CNBr-1 through 5a, b corre-
spond to elution sequence from liquid chromatograph). Arrows
indicate Edman data, underlining denotes sequences determined
by GCMS.
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information made it possible to detect the error and to
correct it.
During these two decades since our first publication
[28] there were very few laboratories, in addition to
ours, which explored or used mass spectrometry for
peptide sequencing. Foremost among them was the
research group of Howard Morris (Imperial College,
London), who used N, O-methylated N-acetyl methyl
esters of small peptides, which could be crudely frac-
tionated directly into the ion source of the mass spec-
trometer [40]. Somewhat later D. F. Hunt used similar
derivatives for chemical ionization and a triple-quadru-
ple mass spectrometer in conjunction with a high-
performance liquid chromatograph to sequence mix-
tures of peptides [41]. All these strategies required
considerable expertise to be used at the sensitivity
required and thus were practiced almost exclusively in
the laboratories where they had been developed. But, as
a consequence, biochemists and biologists had become
aware of the potential of mass spectrometry in protein
chemistry.
The situation started to change dramatically in the
early 1980’s. The late Michael Barber had discovered the
ionization of comparatively large, polar molecules by
“fast atom bombardment” (FAB) [42]. The spectrum of
an undecapeptide ([Met-Lys]-bradykinin) of mol. wt.
1318 opened the way to new strategies in peptide and
protein characterization. It now became possible to
employ proteolytic enzymes of very high structural
specificity, which by necessity produced relatively large
peptides. While our GCMS methodology became al-
most instantly obsolete, we could quickly adapt the
field desorption ion source of our MAT 731 Mattauch-
Herzog type high resolution mass spectrometer to FAB
by installing an argon gun [43].
As a “chemical” ionization method FAB generated
abundant protonated molecule ions of low internal
energy and thus low tendency to fragment. While not
providing much sequence information, it allowed the
reliable measurement of molecular weights of all com-
ponents of a mixture of relatively large peptides with-
out prior separation and at the nanomole level. Thus
FAB-MS made it now possible to solve many problems
quickly, such as the identification of mutant proteins,
detection and corrections of errors in previously sug-
gested sequences, or conversely, the identification of a
protein the sequence of which is known (reviewed in
[44]).
The lack of sequence information, caused by the low
tendency of the protonated molecules generated by
FAB to fragment, was overcome by their collisionally
induced dissociation (CID) in a four-sector magnetic or
triple-quadrupole tandem mass spectrometer. The
former permitted high-energy collisions producing sim-
ple, sequence-specific fragmentation [45]. We used this
approach for the first time in the sequencing of a
number of glutaredoxins [46] and thioredoxins [47],
proteins about 100–110 amino acids in length. In the
course of this work, a computer algorithm for the
interpretation of high energy CID spectra of peptides
(SEQPEP) was developed [48].
Novel ionization techniques continued to revolution-
ize mass spectrometry in general and protein chemistry
in particular. John Fenn had demonstrated that expo-
sure of fine droplets of a solution to a high electric field
generates highly charged ions of even very large mol-
ecules. Not much attention was paid to his work until
he reported the successful ionization of intact proteins
at the 1988 ASMS conference in San Francisco [49]. Then
people took notice and the measurement of molecular
weights by mass spectrometry became commonplace.
One of the major advantages of this method was its
compatibility with the then ubiquitous quadrupole
mass spectrometers, because the high charge state of the
multiprotonated molecules made limited mass range
not an issue. As the analyte had to be in aqueous
solution, direct interfacing with a liquid chromatograph
was ideal for the analysis of complex mixtures by this
method, termed electro-spray ionization (ESI).
In the same year, Hillenkamp and Karas developed
matrix assisted laser desorption ionization (MALDI),
also capable of ionizing intact proteins [50]. This was
even simpler and required less material, but at least at
that time, could only be implemented on a time-of-
flight (TOF) mass spectrometer. As mentioned in the
Instrumentation section above, that instrument flour-
ished briefly in the early 1960’s, but had not been able to
keep up with the ever improving performance of mag-
netic mass spectrometers and the quadrupoles that
followed.
The simplicity of MALDI and its potential got us
interested in its application to the determination of
protein structure. Hillenkamp and Karas had carried
out their experiments by modifying a TOF instrument
designed for laser ionization of inorganic materials.
Rather than duplicating that, we contracted with Vestec
Corporation (Houston, TX) to build a MALDI-TOF
mass spectrometer (following a design of Brian Chait at
Rockefeller University) more suited for peptides and
proteins. The instrument was delivered in October of
1990. This prototype (designated Model 2000) evolved,
after the acquisition of Vestec by PerSeptive Biosystems
(then by Perkin-Elmer which is now Apelera Corp.) into
the Voyager Elite.
The commercial availability of such a powerful in-
strument and methodology at a reasonable price en-
abled many other laboratories to enter this field of
research. The measurement of the molecular weight of a
protein, such as myoglobin, to better than 1 Da [51] or
the unraveling of the (inhomogeneous) pattern of gly-
cosylation at 13 sites in invertase from yeast [52] are
only a few examples from our own work besides that of
many others. The development of powerful computer
techniques for the identification of known or DNA
derived protein sequences originally conceived by Hen-
zel et al. at Genentech [53] and expanded by others a
few years later is particularly noteworthy.
Because of its simplicity, high sensitivity, and ease of
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over-all operation MALDI-MS became the sine qua non
of protein chemistry. The enormous amount of highly
specific and accurate data that can be produced in a
single experiment, requiring only minute amounts of
protein (such as that present in a spot on a 2-D gel)
opened up new dimensions in biological research. The
coincidence of these developments with two others—
the explosion in computer technology that permits the
use of large data bases on a desktop computer and the
unraveling of the sequence of the human genome —led
to a new field, “proteomics”. The rest of it is now
history. This could not have been imagined over forty
years ago, when we first demonstrated the feasibility of
sequencing small peptides by mass spectrometry!
Heparin
To minimize ambiguities when using MALDI-derived
molecular weights of peptides generated by enzymatic
or chemical digestion as well as those of proteins, it was
important to make these measurements as accurate as
possible. In an effort to optimize the experimental
parameters using a series of well defined peptides as
internal standards, Peter Juhasz in our laboratory one
day picked the oxidized A-chain of bovine insulin (Aox)
as the standard and bovine insulin as the “unknown”.
Surprisingly, there was no signal at all at m/z 2552.7 for
the (M  H) ion of the standard, but a very large peak
at m/z 8264.9 in addition to the expected one at m/z
5734.5 for the (M  H) ion of insulin. Puzzled at first
we soon realized that the signal at high mass repre-
sented the protonated complex of the two components
of the mixture, (MAox  Mins  H)
, calculated 8266.3,
caused by the high acidity of Aox, which contains four
sulfonic acid groups in the form of cysteic acid. This
complexing phenomenon, observed by chance, turned
out to be rather general. When a number of highly
acidic compounds we had at hand were mixed with
peptides, they also ionized as protonated complexes.
Not unexpectedly, more basic peptides worked best.
The most highly acidic biologically significant mate-
rials are heparin and other related sulfated glycosami-
noglycans (GAG), like heparan sulfate, chondroitin, etc.
From earlier, unsuccessful efforts to obtain mass spectra
of short heparin fragments we still had left over a
sample of a hexasaccharide with eight sulfuric acid
half-ester groups. An equimolar mixture of 3 pmol
thereof with a tetradodecapeptide of mol. wt. 2942.41
containing seven arginines and two lysines gave an
excellent MALDI spectrum (Figure 15) [54].
The implications of this experiment were very excit-
ing as it opened a possibility for developing a strategy
for the determination of the sequence of fragments of
heparin—and ultimately perhaps of heparin itself
—analogous to that we had developed for peptide and
protein sequencing outlined in the previous section.
The fact that there are no efficient, sensitive, and fast
methods existing for the analysis of these highly acidic
substances made such an effort even more important.
From a procedural point of view, the analogies with
protein sequencing are striking: (1) While proteins are
linear “polymers” of a set of -amino acids, heparin and
its congeners are linear polymers of disaccharides,
consisting of one uronic (glucuronic or iduronic) acid
and one glucosamine (Structure 13); (2) while there are
20 well defined amino acids commonly found in pro-
teins, there are 32 different known modifications of the
repeating disaccharide 13 (depending on the number
and position of sulfate groups or N-acetylation), all of
them differing in mass by at least 4 Da [55]; and (3) like
proteins, which can be degraded specifically by proteo-
lytic enzymes or chemical reactions, heparin can be
Figure 15. MALDI mass spectrum of the complex of the hexas-
accharide shown and a peptide containing seven arginines and
two lysines (reproduced from Reference [54], copyright 1994,
National Academy of Sciences, U.S.A.).
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cleaved enzymatically with heparinases, at specific gly-
cosidic bonds; there are also some oxidative reactions
which split the carbohydrate backbone at certain bonds.
The first step in the design of such a sequencing
strategy was to develop an experimental procedure for
the reliable determination of the true molecular weights
of heparin fragments of the size expected from such
enzymatic or chemical cleavage reactions. Clearly, the
elimination of one to three SO3 groups fromOSO3H to
OH (see Figure 15) must be avoided, because it
simulates the presence of less sulfated molecules. Be-
cause of the quite regular spacing of the acidic groups
along the linear disaccharide backbone it was expected
that complexes with peptides of similar length and
equally spaced arginines (the most basic amino acid)
would be most stable and might thus not fragment. This
turned out to be correct when we began using a
properly designed synthetic peptide (Arg-Gly)n, where
n  10. It was extended to n  15 when it was found
that the number of strongly basic groups in the peptide
must exceed the number of sulfates in the oligosaccha-
ride. The result of these optimization experiments,
which also included the evaluation of various matrices
and wavelengths, is shown in Figure 16. As expected
from these data, the molecular weights of compounds
of different sizes present in a mixture could be mea-
sured reliably. It was also observed that the relative
signal decreases with decreasing number of sulfate
groups. Thus the method is more sensitive for the larger
molecules, the direction desirable for its practical appli-
cation [56].
Thus, the stage was set to explore the sequencing of
heparin fragments by their enzymatic cleavage fol-
lowed by identification of the products by MALDI.
Heparinase I was chosen because the specificity of this
enzyme was best known: It preferentially cleaves at the
glycosidic bond between glucosamine sulfated at the
amino group and the 4-hydroxyl of an iduronic acid
Figure 16. MALDI mass spectrum of the same hexasaccharide as in Figure 15, but complexed with
(Arg-Gly)10 (reproduced from Reference [56], copyright 1960, with permission of Elsevier Science).
Figure 17. MALDI mass spectrum of the complex of (Arg-Gly)15 with the heparinase I digest of the
octasaccharide shown (for details see text).
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moiety sulfated at the 2-hydroxyl. This is an elimination
reaction, leaving two products, one with the glu-
cosamine at the “reducing end”, the other with a
-4,5-dehydro uronic acid at the “non-reducing end”.
An octasaccharide was digested with heparinase I
and aliquots analyzed at various time points by MALDI
after addition of the peptide (Arg-Gly)15. The spectrum
obtained after only 2 min of digestion (Figure 17) shows
that the octasaccharide has been almost completely
degraded. The tetrasaccharide 5–8 which can be formed
from the octasaccharide as well as from the first product
(3–8) is most abundant because heparinase I cleaves
tetrasaccharides only slowly. At this time point the
signals for fragments 3–8 and 1–4 are small but clearly
observable [57].
These results demonstrated the feasibility of se-
quencing heparin and heparin like sulfated polysaccha-
rides by mass spectrometry. In the course of an exten-
sive study [55, 58] the experimental conditions were
optimized using heparinases I and II. To simplify the
sometimes complex mixture of products, capillary elec-
trophoresis was explored successfully. Because some-
times identical subunits can be formed during diges-
tion, it was found useful to mass-label the reducing end
by conversion to a semicarbazone.
During that time we began an extensive collabora-
tion with Professor Ram Sasisekharan and his research
group at MIT, who were interested in exploring the
detailed mechanism of the cleavage of heparin by
heparinases. For that purpose, our method of character-
ization and sequencing of sulfated GAGs was extremely
well suited because it was fast, required little material,
and allowed the following of the time-course of cleav-
age [59–61]. With my official retirement in 1996, grad-
uation of my last student (Andrew Rhomberg) in 1998,
and closing of my research laboratory, I was happy to
transfer the technology, including the Vestec 2000 mass
spectrometer, to that group. It is gratifying to see our
new methodology being applied so quickly to the study
of these important biological processes.
Conclusions
The successful determination of the structure of a
number of indole alkaloids starting in 1958 brought
mass spectrometry, until that time confined to physics,
the petroleum industry, and then analytical chemistry,
to the attention of organic chemists. Academic and
pharmaceutical research laboratories quickly embraced
this methodology and added it to the arsenal of physi-
cal methods now so widely accepted.
At the same time we began to develop a strategy and
procedure to determine the sequences of small peptides
in the complex mixtures produced by the chemical or
enzymatic hydrolysis of proteins. Over about two de-
cades, mass spectrometry emerged as an alternative to
the automated Edman degradation, which it comple-
mented by its ability to determine the end-group and
sequence of N-terminally blocked peptides, long
stretches of hydrophobic amino acid sequences, as well
as the characterization and location of post-translational
modifications. The explosion of new and efficient ion-
ization techniques and developments in instrumenta-
tion, beginning in the late 1980’s, made mass spectro-
metry the preeminent technology in protein research.
The observation that highly acidic compounds, nor-
mally not amenable to mass spectrometry, ionized
efficiently as protonated complexes with well-defined
basic peptides made it possible to determine the molec-
ular weight of heparin fragments and similar highly
sulfated glycosaminoglycans with very high sensitivity.
Based on these experiments, a strategy for the sequenc-
ing of such compounds by their specific cleavage with
enzymes (heparinases) was developed, in analogy to
that which we had so successfully employed for pep-
tides and proteins. This work opens the way to study
the structure, chemistry, and biological function of
heparin and heparin-like glycosaminoglycans, a field so
hampered in the past by the lack of suitable methodol-
ogies.
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